Buscar

01/01/2026 Clinical, endoscopic and histological characteristics of Chlamydia trachomatis proctitis in males
Teller, M, Giordano, A, González-Munoza, C, Gordillo, J, Bertoletti, F, Sánchez-Reus, F, Garcia-Planella, E. Clinical, endoscopic and histological characteristics of Chlamydia trachomatis proctitis in males. Gastroenterologia y Hepatologia. 2026; 49(1)DOI:10.1016/j.gastrohep.2025.502558. PMID:40930415. IF:1.900(Q3/7D).
01/01/2026 Impact of Multiple Sclerosis on the course of Inflammatory Bowel Disease: The MULTIPLEII case-control study from the Young Group of GETECCU
Ramos, CR, Sard, MC, Carballo-Folgoso, L, Ruiz-Rodríguez, J, Moya, MIC, Teller, M, Clotet, AF, Cortés, IL, San Martín, LZ, Moreno, CO, Rivas, C, Cuellar, MA, Elorza, A, Gisbert, J, Martinez, MR, Poceiro, JC, Brunet, E, Caravaca, C, Rey, IB, Piñero, GS, Diaz, AP, Orenga, C, Carrilloramos, MJ, Montero, MG, Sandoval, CT, Velázquez, LM, Olmedo-Martín, R, Catalá, AC, Alonso,, Molina, IGDL, Molina, F, Salmón, P, Giordano, A, Moranta, FR, Zabana, Y, Planella, EG. Impact of Multiple Sclerosis on the course of Inflammatory Bowel Disease: The MULTIPLEII case-control study from the Young Group of GETECCU. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.1197. PMID:. IF:8.700(Q1/1D).
01/01/2026 Prevalence, clinical characterisation and therapeutic outcomes of non-fistulising perianal lesions in Crohn's disease (ULCERS-CD): Results from the ENEIDA registry of GETECCU
Casanova, MJ, Garcia, RMD, Ramos, CL, Camba, AH, Gargayo-Puyuelo, C, Senosiain, BC, Gismero, FM, Pagola, L, Cruañas, AA, Giordano, A, Diaz, AP, Velázquez, LM, Robledo-Andrés, P, Regueiro, C, Gonzalez, MS, Jara, RA, Santos, DC, Glaría, EB, Marquès-Camí, M, Trastoy, PV, Acosta, MBD, de la Osa, DR, Luque, RS, Teller, M, De Célix, CR, Almela, P, Font-Ordeig, G, Bujanda, L, Orenga-Sánchez, C, Oliveras-Font, B, Alvarez, PGI, Sánchez, RM, Guillena, PGD, Arce, NM, Martinez, IP, Alonso, FJG, Ramos, CR, Moral, ED, Chaparro, M, Gisbert, J. Prevalence, clinical characterisation and therapeutic outcomes of non-fistulising perianal lesions in Crohn's disease (ULCERS-CD): Results from the ENEIDA registry of GETECCU. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.960. PMID:. IF:8.700(Q1/1D).
01/01/2026 Comparative study on the effectiveness, durability, and safety of upadacitinib versus risankizumab after anti-TNF failure in Crohn's Disease: The U-PARIS study of ENEIDA
De Célix, CR, Granja, A, Iborra, M, Alonso, FJG, Vela, M, de Castro, L, García-Sola, C, Barrero, S, Trastoy, PV, Andrés, PR, Riestra, S, Diaz, AP, Santos, DC, Camps, B, Gisbert, J, García, MJ, Palomares, MTDL, Lozano, OM, de la Cruz, DR, López, E, Pascual, CM, Izquierdo, S, Flores, EI, Iglesias, RF, Argüelles-Arias, F, Martin, D, Ramírez, MAR, Villaamil, PV, Martinez, AMT, Ramos, CR, Velázquez, LM, Ciria, MM, Brunet, E, Zabana, Y, Villarroya, RP, Altadill, A, Moral, ED, Mateu, PN, Acosta, MBD, San Jose, FB. Comparative study on the effectiveness, durability, and safety of upadacitinib versus risankizumab after anti-TNF failure in Crohn's Disease: The U-PARIS study of ENEIDA. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.069. PMID:. IF:8.700(Q1/1D).
01/01/2026 Safety of biologic and small molecule therapies in IBD patients with previous cancer: risk of recurrence or new neoplasia
Calvo, M, Fernández-Felix, BM, Jiménez, IO, Guardia, JL, Menéndez, SR, Gismero, FM, Parga, MLD, Trastoy, PV, Vela, M, Carrasco, NM, Gargallo-Puyuelo, C, Ramos, CR, Arranz, MDM, Rivas, C, Capón, JG, Garcia, LA, Casbas, AG, San Jose, FB, Gonzalez, S, Lucia, M, Elorza, A, Sepulcre, MFG, Fernández-Salazar, L, Mínguez, A, Quiñones, M, Taxonera, C, Barreiro-de Acosta, M, Diaz, AP, Flores, EI, Cano, MP, Sese, E, Casals, DB, Bas-Cutrina, F, Glaría, EB, Moreno, AZG, Poceiro, JC, Lopez, LR, Moral, ED, Chaparro, M, Gisbert, J. Safety of biologic and small molecule therapies in IBD patients with previous cancer: risk of recurrence or new neoplasia. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.897. PMID:. IF:8.700(Q1/1D).
01/01/2026 Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA
de Célix, CR, Ricart, E, Martín-Arranz, MD, de Francisco, R, García-Alonso, FJ, Mesonero, F, Gomollón, F, de Castro, L, Ramos, L, García-López, S, Arias, L, Mañosa, M, Iglesias, E, Calvet, X, Bolufer, CS, Casanova, MJ, Pérez-Calle, JL, Giordano, A, Sierra-Ausín, M, Vera, I, Navarro-Llavat, M, Lorente, R, Piqueras, M, Rivero, M, Guardiola, J, Esteve, M, Coronel, AF, Rodríguez-Lago, I, Ponferrada-Díaz, A, Ber, Y, Tardillo, C, Márquez, L, Carpio, D, Taxonera, C, Bermejo, F, Busquets, D, Camps, B, Gutiérrez, A, García-Sepulcre, MF, Barreiro-de Acosta, M, Marín-Jiménez, I, Huguet, JM, Fernández-Salazar, LI, Jaó, J, Rodríguez-Gutiérrez, C, Martinez-Flores, C, Bujanda, L, Lucendo, AJ, Sesé, E, Andrés, PR, Ginard, D, Vega, P, Riera, J, Pajares, R, Van Domselaar, M, Almela, P, Pérez, TM, Muñoz-Villafranca, C, Varela, P, Argüelles-Arias, F, Nos, P, Alcaín, G, Hernández, L, Fernández, H, Muñoz, F, Gilabert, P, Navas-López, VM, de la Piscina, PR, Sánchez, LB, Gil, JL, Valldosera, G, Muñoz, RA, Frago, S, Domènech, E, Chaparro, M, Gisbert, JP. Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; 63(1)DOI:10.1111/apt.70312. PMID:40778752. IF:6.700(Q1/1D).
01/01/2026 Small bowel capsule endoscopy and ileocolonoscopy for activity grading in ileal Crohn's disease, a comparative analysis. Results from the CAPITER study, a multicenter study from the Young GETECCU Group
Marquès-Camí, M, Vergés, L, Gonzalez, AE, Huguet, JM, Mateos, AMC, Caravaca, C, Molina, IGD, Suárez, C, Carballo-Folgoso, L, Vivo, MG, Cuadro, CP, Vicente, GT, Martin, MDCL, Ramos, CR, Jimenez, BV, Clotet, AF, Sandoval, CT, Torres, VM, Intriago, AC, Brunet, E, Martín, J, Marin, CAT, Medina, LT, Lozano, OM, Mínguez, A, Velázquez, LM, Sard, MC, Zabana, Y. Small bowel capsule endoscopy and ileocolonoscopy for activity grading in ileal Crohn's disease, a comparative analysis. Results from the CAPITER study, a multicenter study from the Young GETECCU Group. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.468. PMID:. IF:8.700(Q1/1D).
01/01/2026 Clinical and biological factors as predictors of mucosal healing in moderate ulcerative colitis treated with steroids
Ciria, MM, Guardia, JL, Piñero, GS, Sard, MC, Arranz, EM, Zabana, Y, Llavat, MN, Teller, M, Planella, EG, Casals, DB, Miquel, DM, Juan-Ramón, P, Casbas, AG, Ferrer, AV, Viso, LAM, Paz, GB, Alonso, FJG, Tirado, MR, Chaparro, M, Menéndez, SR, Ochoa, OM, Rodríguez-Lago,, Acosta, MBD, Rodríguez-Fortúnez, P, Moral, ED. Clinical and biological factors as predictors of mucosal healing in moderate ulcerative colitis treated with steroids. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.463. PMID:. IF:8.700(Q1/1D).